Paroxysmal nocturnal hemoglobinuria pathophysiology: Difference between revisions

	Paroxysmal nocturnal hemoglobinuria Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Paroxysmal nocturnal hemoglobinuria from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Paroxysmal nocturnal hemoglobinuria pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Paroxysmal nocturnal hemoglobinuria pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Paroxysmal nocturnal hemoglobinuria pathophysiology
CDC on Paroxysmal nocturnal hemoglobinuria pathophysiology
Paroxysmal nocturnal hemoglobinuria pathophysiology in the news
Blogs on Paroxysmal nocturnal hemoglobinuria pathophysiology
Directions to Hospitals Treating Paroxysmal nocturnal hemoglobinuria
Risk calculators and risk factors for Paroxysmal nocturnal hemoglobinuria pathophysiology

← Older edit Newer edit →

VisualWikitext

Revision as of 16:24, 2 July 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR

[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Pathophysiology

Physiology

The normal physiology of [name of process] can be understood as follows:

Pathogenesis

The exact pathogenesis of [disease name] is not completely understood.

OR

It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
The progression to [disease name] usually involves the [molecular pathway].
The pathophysiology of [disease/malignancy] depends on the histological subtype.

Genetics

[Disease name] is transmitted in [mode of genetic transmission] pattern.

OR

Genes involved in the pathogenesis of [disease name] include:

[Gene1]
[Gene2]
[Gene3]

OR

The development of [disease name] is the result of multiple genetic mutations such as:

[Mutation 1]
[Mutation 2]
[Mutation 3]

Associated Conditions

Gross Pathology

On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Microscopic Pathology

On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

References

Template:WH Template:WS

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{ Paroxysmal nocturnal hemoglobinuria }}
+{{Paroxysmal nocturnal hemoglobinuria}}
-{{CMG}}
+{{CMG}}; {{AE}}
 ==Overview==
+The exact pathogenesis of [disease name] is not fully understood.
+OR
+It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
+OR
+[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
+OR
+Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
+OR
+[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
+OR
+The progression to [disease name] usually involves the [molecular pathway].
+OR
+The pathophysiology of [disease/malignancy] depends on the histological subtype.
 ==Pathophysiology==
-All cells have proteins attached to their membranes that are responsible for performing a vast array of functions. There are several ways for proteins to be attached to a cell membrane. [[PNH]] occurs as a result of a defect in one of these mechanisms.
+===Physiology===
+The normal physiology of [name of process] can be understood as follows:
+===Pathogenesis===
+*The exact pathogenesis of [disease name] is not completely understood.
+OR
+*It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
+*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
+*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
+*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
+*The progression to [disease name] usually involves the [molecular pathway].
+*The pathophysiology of [disease/malignancy] depends on the histological subtype.
+==Genetics==
+[Disease name] is transmitted in [mode of genetic transmission] pattern.
-It is thought to be an acquired disease with the clonal expansion of pluripotent stem cells containing the somatic mutation of an X-linked (short arm of X-chromosome) PIG-A (for phosphatidylinositol glycan class A) gene.<ref>Hu R, Mukhina GL, Piantadosi S, Barber JP, Jones RJ, Brodsky RA. ''PIG-A mutations in normal hematopoiesis.'' Blood 2005;105:3848-54. PMID 15687243.</ref>  The gene that codes for PIG-A is inherited in an [[Sex linkage|X-linked]] fashion. This gene is involved in the first step of the synthesis of the glucosylphosphatidyl-inositol anchor of GPI membrane proteins such as CD55, CD59, CD14 and others (CD is an acronym for 'cluster of differentiation').  Mutations in the PIG-A gene cause a deficiency of the glucosylphophatidylinositol-anchored proteins in PNH hematopoietic cells (all 3 cell lines can be affected).  Two of these proteins, CD55 and CD59, are complement regulatory proteins; the absence of these proteins is fundamental to the pathophysiology of this disease.  The complement system is the part of the immune system that helps to destroy invading microorganisms.  The presence of CD55 and CD59 confers resistance to the body's blood cells from lysis by complement.  CD55 inhibits C3 convertase and CD59 blocks the formation of the membrane attack complex (MAC) by inhibiting the incorporation of C9 into the MAC.  The loss of these complement regulatory proteins renders PNH erythrocytes susceptible to both intravascular and extravascular hemolysis but it is the intravascular hemolysis that contributes to much of the morbidity of this disease.
+OR
-The increased destruction of red blood cells results in [[anemia]]. The increased rate of thrombosis is due to dysfunction of [[platelet]]s.  They are also made by the bone marrow stem cells and will have the same GPI anchor defect as the red blood cells.  The proteins which use this anchor are needed for platelets to clot properly, and their absence leads to a hypercoagulable state.
+Genes involved in the pathogenesis of [disease name] include:
+*[Gene1]
+*[Gene2]
+*[Gene3]
+OR
+The development of [disease name] is the result of multiple genetic mutations such as:
+*[Mutation 1]
+*[Mutation 2]
+*[Mutation 3]
+==Associated Conditions==
+==Gross Pathology==
+On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
+==Microscopic Pathology==
+On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
 ==References==
 {{Reflist|2}}
-[[Category:Hematology]]
-[[Category:Rheumatology]]
-[[Category:Mature chapter]]
 {{WH}}
 {{WS}}
+[[Category: (name of the system)]]